FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1547277915> ?p ?o ?g. }

• W1547277915 endingPage "289" @default.
• W1547277915 startingPage "279" @default.
• W1547277915 abstract "The object of this study was to assess whether a capsule-based and multidose dry powder inhaler containing salmeterol (as xinafoate salt) 50 μg plus fluticasone propionate (FP) 250 μg [combination (SFC 50/250)] could be equivalent in terms of in vivo drug delivery and systemic exposure.This was a randomized, double-blind, double-dummy, replicate treatment design comparative bioavailability study of SFC 50/250 delivered in a capsule-based inhaler (Rotahaler®) and a multidose dry powder inhaler (Diskus®). Subjects with asthma or chronic obstructive pulmonary (COPD) disease (n=60) were randomized to receive twice-daily SFC 50/250 via a Rotahaler and via Diskus each for two 10-day treatment periods (GlaxoSmithKline Protocol ASR114334).For FP and salmeterol, the in vitro aerodynamic particle size profiles were within±15% of Diskus for the fine particle mass (FPM) and emitted dose (ED) using the Andersen Cascade Impactor, and ED, mass median aerodynamic diameter, and geometric standard deviation using the New Generation Impactor (NGI). This was also the case for FP but not salmeterol for FPM and fine particle dose using the NGI. For the combined asthma and COPD subjects, the plasma AUC and Cmax for FP and salmeterol were higher for Rotahaler:Rotahaler/Diskus geometric mean ratios (90% confidence intervals) for FP AUC0-τ of 1.52 (1.37-1.67) and Cmax of 1.94 (1.75-2.10) and salmeterol AUC0-τ of 1.15 (1.09-1.21) and Cmax of 1.56 (1.42-1.67). Corresponding values for the primary pharmacodynamic endpoint, weighted mean (0-12 hr) serum cortisol, were 0.928 (0.886-0.971). Inhaled FP/salmeterol via both inhalers was well-tolerated. One serious adverse event, considered possibly related to study medication, resulted in subject withdrawal from the study.The in vitro tests and systemic pharmacodynamic endpoints revealed no major differences between the two inhalers, but lacked predictive power and sensitivity to guide in vivo drug delivery performance and systemic exposure. Based on pharmacokinetic endpoints, the inhalers were not considered bioequivalent in terms of systemic exposure. Further studies to refine the Rotahaler performance are ongoing." @default.
• W1547277915 created "2016-06-24" @default.
• W1547277915 creator A5003470779 @default.
• W1547277915 creator A5003926756 @default.
• W1547277915 creator A5030652345 @default.
• W1547277915 creator A5036422356 @default.
• W1547277915 creator A5038421273 @default.
• W1547277915 date "2014-08-01" @default.
• W1547277915 modified "2023-09-27" @default.
• W1547277915 title "Pharmacokinetics and Pharmacodynamics of Fluticasone Propionate and Salmeterol Delivered as a Combination Dry Powder from a Capsule-Based Inhaler and a Multidose Inhaler in Asthma and COPD Patients" @default.
• W1547277915 cites W1578895330 @default.
• W1547277915 cites W1985584819 @default.
• W1547277915 cites W2001834696 @default.
• W1547277915 cites W2105382761 @default.
• W1547277915 cites W2113302513 @default.
• W1547277915 cites W2143585992 @default.
• W1547277915 cites W2405499044 @default.
• W1547277915 doi "https://doi.org/10.1089/jamp.2013.1040" @default.
• W1547277915 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24074143" @default.
• W1547277915 hasPublicationYear "2014" @default.
• W1547277915 type Work @default.
• W1547277915 sameAs 1547277915 @default.
• W1547277915 citedByCount "30" @default.
• W1547277915 countsByYear W15472779152014 @default.
• W1547277915 countsByYear W15472779152015 @default.
• W1547277915 countsByYear W15472779152016 @default.
• W1547277915 countsByYear W15472779152017 @default.
• W1547277915 countsByYear W15472779152018 @default.
• W1547277915 countsByYear W15472779152019 @default.
• W1547277915 countsByYear W15472779152020 @default.
• W1547277915 countsByYear W15472779152021 @default.
• W1547277915 countsByYear W15472779152022 @default.
• W1547277915 countsByYear W15472779152023 @default.
• W1547277915 crossrefType "journal-article" @default.
• W1547277915 hasAuthorship W1547277915A5003470779 @default.
• W1547277915 hasAuthorship W1547277915A5003926756 @default.
• W1547277915 hasAuthorship W1547277915A5030652345 @default.
• W1547277915 hasAuthorship W1547277915A5036422356 @default.
• W1547277915 hasAuthorship W1547277915A5038421273 @default.
• W1547277915 hasConcept C111113717 @default.
• W1547277915 hasConcept C112705442 @default.
• W1547277915 hasConcept C126322002 @default.
• W1547277915 hasConcept C142724271 @default.
• W1547277915 hasConcept C204787440 @default.
• W1547277915 hasConcept C22979827 @default.
• W1547277915 hasConcept C27081682 @default.
• W1547277915 hasConcept C2776042228 @default.
• W1547277915 hasConcept C2776136866 @default.
• W1547277915 hasConcept C2776719499 @default.
• W1547277915 hasConcept C2776780178 @default.
• W1547277915 hasConcept C2777419714 @default.
• W1547277915 hasConcept C2779028295 @default.
• W1547277915 hasConcept C2779871671 @default.
• W1547277915 hasConcept C2780261241 @default.
• W1547277915 hasConcept C2781018748 @default.
• W1547277915 hasConcept C2781212218 @default.
• W1547277915 hasConcept C42219234 @default.
• W1547277915 hasConcept C42404028 @default.
• W1547277915 hasConcept C71924100 @default.
• W1547277915 hasConcept C87813604 @default.
• W1547277915 hasConcept C98274493 @default.
• W1547277915 hasConceptScore W1547277915C111113717 @default.
• W1547277915 hasConceptScore W1547277915C112705442 @default.
• W1547277915 hasConceptScore W1547277915C126322002 @default.
• W1547277915 hasConceptScore W1547277915C142724271 @default.
• W1547277915 hasConceptScore W1547277915C204787440 @default.
• W1547277915 hasConceptScore W1547277915C22979827 @default.
• W1547277915 hasConceptScore W1547277915C27081682 @default.
• W1547277915 hasConceptScore W1547277915C2776042228 @default.
• W1547277915 hasConceptScore W1547277915C2776136866 @default.
• W1547277915 hasConceptScore W1547277915C2776719499 @default.
• W1547277915 hasConceptScore W1547277915C2776780178 @default.
• W1547277915 hasConceptScore W1547277915C2777419714 @default.
• W1547277915 hasConceptScore W1547277915C2779028295 @default.
• W1547277915 hasConceptScore W1547277915C2779871671 @default.
• W1547277915 hasConceptScore W1547277915C2780261241 @default.
• W1547277915 hasConceptScore W1547277915C2781018748 @default.
• W1547277915 hasConceptScore W1547277915C2781212218 @default.
• W1547277915 hasConceptScore W1547277915C42219234 @default.
• W1547277915 hasConceptScore W1547277915C42404028 @default.
• W1547277915 hasConceptScore W1547277915C71924100 @default.
• W1547277915 hasConceptScore W1547277915C87813604 @default.
• W1547277915 hasConceptScore W1547277915C98274493 @default.
• W1547277915 hasIssue "4" @default.
• W1547277915 hasLocation W15472779151 @default.
• W1547277915 hasLocation W15472779152 @default.
• W1547277915 hasOpenAccess W1547277915 @default.
• W1547277915 hasPrimaryLocation W15472779151 @default.
• W1547277915 hasRelatedWork W1547277915 @default.
• W1547277915 hasRelatedWork W2074519860 @default.
• W1547277915 hasRelatedWork W2086416159 @default.
• W1547277915 hasRelatedWork W2113302513 @default.
• W1547277915 hasRelatedWork W2154436876 @default.
• W1547277915 hasRelatedWork W2158529533 @default.
• W1547277915 hasRelatedWork W2188849813 @default.
• W1547277915 hasRelatedWork W2789391026 @default.
• W1547277915 hasRelatedWork W2984327395 @default.
• W1547277915 hasRelatedWork W3136671182 @default.

• next